Filing Details

Accession Number:
0001610717-24-000205
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-12 16:23:40
Reporting Period:
2024-04-10
Accepted Time:
2024-04-12 16:23:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD Biological Products, (No Disgnostic Substances) (2836) 472029180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1860609 Sushil Patel C/O Revolution Medicines, Inc.
700 Saginaw Dr
Redwood City CA 94063
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-10 2,155 $16.80 17,855 No 4 M Direct
Common Stock Disposition 2024-04-10 2,155 $37.00 15,700 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-04-10 2,155 $0.00 2,155 $16.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,645 2032-06-15 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on September 7, 2023.
  2. Includes 10,450 restricted stock units.
  3. The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of June 16, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.